We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App





Novel Approach to COVID-19 Testing May Lead to Much Faster, Less Expensive and More Accurate Tests

By LabMedica International staff writers
Posted on 22 Dec 2021
Print article
Image: Novel Approach to COVID-19 Testing May Lead to Much Faster, Less Expensive and More Accurate Tests  (Photo courtesy of MIT researchers)
Image: Novel Approach to COVID-19 Testing May Lead to Much Faster, Less Expensive and More Accurate Tests (Photo courtesy of MIT researchers)

Using mathematical simulations, researchers have shown that it would be possible to design a sensor, based on quantum physics that could detect the SARS-CoV-2 virus.

This novel approach to testing developed by researchers at the Massachusetts Institute of Technology (MIT; Cambridge, MA, USA) for the presence of the virus that causes COVID-19 may lead to tests that are faster, less expensive, and potentially less prone to erroneous results than existing detection methods. Though the work, based on quantum effects, is still theoretical, these detectors could potentially be adapted to detect virtually any virus. Existing tests for the SARS-CoV-2 virus include rapid tests that detect specific viral proteins, and polymerase chain reaction (PCR) tests that take several hours to process. Neither of these tests can quantify the amount of virus present with high accuracy. Even the gold-standard PCR tests might have false-negative rates of more than 25%.

In contrast, the team’s analysis shows the new test could have false negative rates below 1%. The test could also be sensitive enough to detect just a few hundred strands of the viral RNA, within just a second. The new approach makes use of atomic-scale defects in tiny bits of diamond, known as nitrogen vacancy (NV) centers. These tiny defects are extremely sensitive to minute perturbations, thanks to quantum effects taking place in the diamond’s crystal lattice, and are being explored for a wide variety of sensing devices that require high sensitivity.

The new method would involve coating the nanodiamonds containing these NV centers with a material that is magnetically coupled to them and has been treated to bond only with the specific RNA sequence of the virus. When the virus RNA is present and bonds to this material, it disrupts the magnetic connection and causes changes in the diamond’s fluorescence that are easily detected with a laser-based optical sensor.

The sensor uses only low-cost materials (the diamonds involved are smaller than specks of dust), and the devices could be scaled up to analyze a whole batch of samples at once, the researchers say. The gadolinium-based coating with its RNA-tuned organic molecules can be produced using common chemical processes and materials, and the lasers used to read out the results are comparable to cheap, widely available commercial green laser pointers.

While this initial work was based on detailed mathematical simulations that proved the system can work in principle, the team is continuing to work on translating that into a working lab-scale device to confirm the predictions. Their plan is first to do a basic proof-of-principle lab test, and then to work on ways to optimize the system to make it work on real virus diagnosis applications. The multidisciplinary process requires a combination of expertise in quantum physics and engineering, for producing the detectors themselves, and in chemistry and biology, for developing the molecules that bind with the viral RNA and for finding ways to bond these to the diamond surfaces.

Even if complications arise in translating the theoretical analysis into a working device, the researchers believe that there is such a large margin of lower false negatives predicted from this work that it will likely still have a strong advantage over standard PCR tests in that regard. And even if the accuracy were the same, this method would still have a major advantage in producing its results with a matter of minutes, rather than requiring several hours. According to the researchers, the basic method can be adapted to any virus, including any new ones that may arise, simply by adapting the compounds that are attached to the nanodiamond sensors to match the generic material of the specific target virus.

“The proposed approach is appealing both for its generality and its technological simplicity,” said David Glenn, senior research scientist at Quantum Diamond Technologies Inc., who was not associated with this work. “In particular, the sensitive, all-optical detection technique described here requires minimal instrumentation compared to other methods that employ nitrogen vacancy centers.”

Related Links:
Massachusetts Institute of Technology 

Automated ELISA-IFA-BLOT Processor AP 22
Gold Supplier
COVID-19 Real Time RT-PCR Kit
respiraScreen 1
New
Semi-Auto Urine Test Strip Analyzer
HTI CL-50 Plus
New
Automatic Specific Protein Analyzer
PA 900

Print article

Channels

Molecular Diagnostics

view channel
Image: A new method reliably detects protein changes in blood that are typical of Parkinson`s disease (Photo courtesy of Pexels)

First-Ever Blood Test Detects Parkinson’s Disease

Until now, the diagnosis of Parkinson's disease has been based primarily on typical movement disorders such as muscle stiffness, slower movements and shaking. However, the disease starts up to 20 years... Read more

Industry

view channel
Image: Fujirebio has acquired ADx NeuroSciences for 40 million Euros (Photo courtesy of Pexels)

Fujirebio Acquires ADx NeuroSciences to Speed Development of Neurodegenerative Diseases Diagnostic Tests

Fujirebio Holdings, Inc. (Tokyo, Japan) has announced the acquisition of ADx NeuroSciences (Gent, Belgium) for EUR 40 million in a deal that is expected to close in July 2022, pending the satisfaction... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.